Milestone Venture

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
2
Rounds led
0
Rounds' value
$30.0M
total disclosed, rounds participated
Stages
—

Portfolio · 1

Chemomab Therapeutics
Innovative Treatments for Patients with Fibro-Inflammatory-Related Diseases
2 rounds $30.0M committed Latest: 2019-12

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Milestone Venture's most notable exit?
Milestone Venture's most notable exit is Chemomab Therapeutics, which completed a reverse merger in March 2021 and is now publicly traded on NASDAQ.
Which sectors does Milestone Venture focus on for investments?
Milestone Venture shows a concentration in Health Tech & Life Sciences, with one of its portfolio companies, Chemomab Therapeutics, operating in this sector. They also have investments in Business Software.
What is the funding stage focus of Milestone Venture?
Milestone Venture has participated in various funding stages, including a B Round, a C Round, and Convertible Debt rounds.
When was Milestone Venture most active in making new investments?
Milestone Venture had investment activity in December 2017, April 2019, and December 2019, with one new portfolio company added in December 2017.
Can you name a key portfolio company for Milestone Venture?
A key portfolio company for Milestone Venture is Chemomab Therapeutics, which focuses on innovative treatments for fibro-inflammatory-related diseases.
What is Milestone Venture's investment range?
Milestone Venture's investment range is between $175K and $20M.